Clinical Trial Update: Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for beta blockers and angiotensin receptor blockers in bicuspid aortic valve disease (aortopathy) has been terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortopathy
• Bicuspid Aortic Valve Disease
• Cardiac Disease

Drugs mentioned

• angiotensin receptor blockers (angiotensin receptor blockers)
• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Cardiac Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-09-18